Detalles de la búsqueda
1.
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Hepatol Res
; 52(6): 508-521, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129841
2.
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
Hepatol Res
; 52(7): 586-596, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35352445
3.
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.
Carcinogenesis
; 42(1): 58-69, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449510
4.
Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.
BMC Infect Dis
; 21(1): 389, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906643
5.
High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C.
Hepatol Res
; 50(6): 671-681, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32020702
6.
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
Hepatol Res
; 50(8): 966-977, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562334
7.
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.
J Gastroenterol Hepatol
; 35(10): 1782-1788, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32187734
8.
Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
Hepatol Res
; 49(10): 1207-1217, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31219667
9.
Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.
Hepatol Res
; 48(3): E311-E319, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28984014
10.
Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction.
Hepatol Res
; 48(7): 529-538, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29316051
11.
Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.
Hepatol Res
; 48(3): E146-E154, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28722780
12.
Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.
J Med Virol
; 89(2): 267-275, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27459003
13.
Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma.
Hepatol Res
; 47(6): 533-541, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27423140
14.
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.
Hepatol Res
; 47(11): 1127-1136, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27943523
15.
Investigation of the utility of various diagnostic guidelines for Wilson's disease.
Nihon Shokakibyo Gakkai Zasshi
; 114(5): 839-845, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-28484195
16.
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection.
Hepatol Res
; 46(13): 1294-1303, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26896756
17.
[Clinical impact of addition of bevacizumab to the first-line chemotherapy regimen in the treatment of patients with metastatic colorectal cancer].
Gan To Kagaku Ryoho
; 41(9): 1113-7, 2014 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-25248894
18.
Durable response without recurrence to Tolvaptan improves long-term survival.
J Gastroenterol
; 55(12): 1150-1161, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32851487
19.
Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.
JGH Open
; 4(5): 880-888, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33102759
20.
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting.
JGH Open
; 4(1): 54-60, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32055698